Dynavax Technologies Corporation

Stock Chart, Company Information, and Scan Results

$15.38(as of Dec 24, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Dynavax Technologies Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$15.38
Ticker SymbolDVAX
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees405
CountyUSA
Market Cap$1,806.0M
EBIDTA24.2M
10-Day Moving Average11.35
P/E Ratio-48.36
20-Day Moving Average11.17
Forward P/E Ratio29.24
50-Day Moving Average10.85
Earnings per Share-0.37
200-Day Moving Average10.77
Profit Margin28.38%
RSI89.44
Shares Outstanding117.4M
ATR0.57
52-Week High15.49
Volume30,747,058
52-Week Low9.20
Most Recent Support Level10.78
Book Value534.1M
Most Recent Resistance Level11.29
P/B Ratio3.93
Upper Keltner12.46
P/S Ratio6.35
Lower Keltner9.89
Debt-to-Equity Ratio12.46
Next Earnings Date02/19/2026
Cash Surplus53.4M
Next Ex-Dividend DateUnknown

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Dynavax Technologies Corporation In Our Stock Scanner

As of Dec 26, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.